Pharmafile Logo
Pharmafocus logo
Advanced Search
lars-rebien-soerensen

Novo chief executive ranked ‘world’s best’

October 14, 2015
Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk

Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …

Appointment
boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015
Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …

News
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015
Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …

Appointment

Merck rebrands as ‘science and technology’ company

October 14, 2015
Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

News
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015
Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …

News
dna

Featured Market Report: Gene Therapies Outlook

October 13, 2015
Manufacturing and Production, Research and Development

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …

Feature
cinryze_logo

Shire’s Cinryze gets FDA fast track designation

October 13, 2015
Research and Development AMR, FDA, Shire

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …

News
medimmune_2

AstraZeneca’s MedImmune joins Human Vaccines Project

October 13, 2015
Research and Development Human Vaccines Project, MedImmune

MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …

News
gamidi_cell_logo

Novartis invests further $15m into Gamida Cell

October 13, 2015
Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …

News
s_oschmann_2015

Stefan Oschmann promoted to top job at Merck KGaA

October 13, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …

Appointment
oma_nice

NICE launches new service to speed NHS adoption of health technologies

October 13, 2015
Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access

NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …

News
manufacturing China

Contact manufacturing ‘is changing the industry’, report finds

October 13, 2015
Manufacturing and Production CMO, contract manufacturing, manufacturing, pharma, production

The global market for pharma and biopharma contract manufacturing is expected to reach more than €332.7 billion by 2018, according …

News
berg_niven_narain

Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015
Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …

Feature

AstraZeneca halts lung cancer trials amidst safety concerns

October 13, 2015
Manufacturing and Production AZD9291, AstraZeneca, MEDI4736, NSCLC, drug safety, durvalumab, interstitial lung disease, lung cancer, non-small cell lung cancer

AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …

News
998056_515738608494989_261353558_n

Merck improves manufacturing program

October 13, 2015
Manufacturing and Production Merck, Merck Millipore, manufacturing, production

Merck Millipore, the life science business arm of Merck KGaA, has introduced enhancements to its Emprove portfolio of raw pharmaceutical …

News
lilly_entrance_web

Lilly shares fall as company abandons evacetrapib development

October 13, 2015
Manufacturing and Production evacetrapib, high cholesterol, lilly, phase III, phase III failure

Eli Lilly shares fell by nearly 8% this week as the company announced it will abandon developmenty of the investigational …

News
afinitor_logo

Blow for Scottish women as SMC rejects Afinitor for advanced breast cancer

October 12, 2015
Sales and Marketing SMC, advanced breast cancer

The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …

News
zytiga

New cancer medicines approved in Scotland, available via NHS

October 12, 2015
Sales and Marketing Scottish Medicines Consortium, Zytiga, abiraterone acetate, prostate cancer

The Scottish Medicines Consortium (SMC) has today recommended Janssen’s Zytiga (abiraterone acetate) for use before chemotherapy in men with advanced …

News
abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015
Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …

News
think_big_on_genomics_research

Time for pharma to think big on genomics research

October 12, 2015
Research and Development Sir John Chisholm, genomics

Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …

Feature
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026